Lexeo Therapeutics News

Lexeo Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

Sep 10 16:44 ET

Lexeo Therapeutics | 424B3: Prospectus

Aug 12 07:15 ET

Lexeo Therapeutics | 424B3: Prospectus

Jul 15 08:04 ET

Lexeo Therapeutics | 424B3: Prospectus

Jul 8 07:07 ET

Lexeo Therapeutics | 424B3: Prospectus

Jun 28 07:37 ET

Lexeo Therapeutics | 144: Notice of proposed sale of securities pursuant to Rule 144

May 13 17:19 ET

Lexeo Therapeutics | 424B3: Prospectus

May 9 07:12 ET

Lexeo Therapeutics | 424B3: Prospectus

Apr 22 08:30 ET

Lexeo Therapeutics | 424B3: Prospectus

Apr 22 08:25 ET

Lexeo Therapeutics | 424B3: Prospectus

Apr 16 07:39 ET

Lexeo Therapeutics | EFFECT: Others

Apr 15 06:19 ET

Lexeo Therapeutics | 424B3: Prospectus

Apr 12 17:08 ET

Lexeo Therapeutics | 424B4: Prospectus

Nov 6, 2023 16:54 ET

Lexeo Therapeutics | EFFECT: Others

Nov 3, 2023 00:16 ET

Lexeo Therapeutics | FWP: Filing under Securities Act Rules 163/433 of free writing prospectuses

Nov 2, 2023 21:01 ET

Lexeo Therapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Nov 1, 2023 16:01 ET